关于这一集
Mark and Howard are joined by Sarah Holland, Chief Business Officer at Swiss biotech CDR Life and President of the Swiss Healthcare Licensing Group, to explore what intelligence looks like in the private sector.
Sarah explains how biotech companies use competitive intelligence, scientific data, market insight, expert networks, conferences, regulatory signals, and even industry gossip to make high-stakes decisions about drug development and partnerships.
英语
美国
文字稿 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
本播客中的其他单集
Surveillance has evolved from intercepting what people deliberately communicate to detecting what they involuntarily reveal. Who controls these capabilities? Can legislation and oversight keep pace? And what happens when surveillance no longer requires us to communicate or even carry a device?
C...
Carmen Medina, former CIA Deputy Director of Intelligence, returns to The Collators to discuss her new project capturing the hard-won lessons, adages and mental cues that help analysts think better.
The conversation becomes a deep exploration of what analysis actually is. What happens between re...
Dean Baratta joins The Collators to discuss a career that has taken him from Cold War military intelligence to law enforcement, homeland security, and the private sector. Dean also reflects on the future of the field, the danger of losing apprenticeship style learning, and why the next generation...
This week, we are doubly blessed to welcome back a very special guest: Konstantin from the Inside Russia YouTube channel. Moving past regular news cycles, we sit down for a deep, philosophical, and deeply personal conversation about the global information shift and the decaying trust in our media...
免责声明: 本页面嵌入的播客和封面图片来自 Mark Lockwood, Howard Atkin，归其所有者所有，与 Listen Notes, Inc. 无关联，也未获得 Listen Notes, Inc. 背书。
